{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:07:13Z","timestamp":1793315233071,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7976","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,8,31]]},"DOI":"10.1038\/s41586-023-06421-w","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T16:04:20Z","timestamp":1692201860000},"page":"1063-1070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Interferon-\u03b5 is a tumour suppressor and restricts ovarian cancer"],"prefix":"10.1038","volume":"620","author":[{"given":"Zoe R. C.","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-274X","authenticated-orcid":false,"given":"Nicole K.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh E.","family":"Mangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra J.","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-3056","authenticated-orcid":false,"given":"Linden J.","family":"Gearing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2342-2559","authenticated-orcid":false,"given":"Antony Y.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodee A.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgie","family":"Wray-McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7820-1484","authenticated-orcid":false,"given":"Sarah","family":"Rosli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Brockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-1926","authenticated-orcid":false,"given":"Belinda S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree","family":"Bilandzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"de Geus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-4698","authenticated-orcid":false,"given":"Matthew J.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Yaw","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Australian Ovarian Cancer Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"DeFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Traficante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fereday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hendley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-7586","authenticated-orcid":false,"given":"Iain A.","family":"McNeish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D. L.","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"de Weerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3689-5956","authenticated-orcid":false,"given":"Clare L.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4313-6859","authenticated-orcid":false,"given":"Nollaig M.","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-8472","authenticated-orcid":false,"given":"Paul J.","family":"Hertzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"6421_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"A-M Patch","year":"2015","unstructured":"Patch, A.-M. et al. Whole\u2013genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"6421_CR2","unstructured":"US Cancer Statistics Working Group. US Cancer Statistics Data Visualizations Tool, based on 2019 submission data (1999\u20132017). Centers for Disease Control and Prevention www.cdc.gov\/cancer\/dataviz (2020)."},{"key":"6421_CR3","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson, G. C., Kohn, E. C., Kitchener, H. C. & Ledermann, J. A. Ovarian cancer. Lancet 384, 1376\u20131388 (2014).","journal-title":"Lancet"},{"key":"6421_CR4","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill, R. W. et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198\u20135208 (2008).","journal-title":"Clin. Cancer Res."},{"key":"6421_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719\u2013725 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"6421_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41571-021-00532-x","volume":"18","author":"MP Dias","year":"2021","unstructured":"Dias, M. P., Moser, S. C., Ganesan, S. & Jonkers, J. Understanding and overcoming resistance to PARP inhibitors in cancer therapy. Nat. Rev. Clin. Oncol. 18, 773\u2013791 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"6421_CR7","doi-asserted-by":"publisher","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","volume":"309","author":"TL Yeung","year":"2015","unstructured":"Yeung, T. L. et al. Cellular and molecular processes in ovarian cancer metastasis. Am. J. Physiol. 309, C444\u2013C456 (2015).","journal-title":"Am. J. Physiol."},{"key":"6421_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2017.00024","volume":"7","author":"T Worzfeld","year":"2017","unstructured":"Worzfeld, T. et al. The unique molecular and cellular microenvironment of ovarian cancer. Front. Oncol. 7, 24 (2017).","journal-title":"Front. Oncol."},{"key":"6421_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.14","volume":"16","author":"BS Parker","year":"2016","unstructured":"Parker, B. S., Rautela, J. & Hertzog, P. J. Antitumour actions of interferons: implications for cancer therapy. Nat. Rev. Cancer 16, 131\u2013144 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"6421_CR10","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1126\/science.1233321","volume":"339","author":"KY Fung","year":"2013","unstructured":"Fung, K. Y. et al. Interferon-\u03b5 protects the female reproductive tract from viral and bacterial infection. Science 339, 1088\u20131092 (2013).","journal-title":"Science"},{"key":"6421_CR11","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1074\/jbc.M117.800755","volume":"293","author":"SA Stifter","year":"2018","unstructured":"Stifter, S. A. et al. Defining the distinct, intrinsic properties of the novel type I interferon, IFN\u03f5. J. Biol. Chem. 293, 3168\u20133179 (2018).","journal-title":"J. Biol. Chem."},{"key":"6421_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ygeno.2004.03.003","volume":"84","author":"MP Hardy","year":"2004","unstructured":"Hardy, M. P., Owczarek, C. M., Jermiin, L. S., Ejdeb\u00e4ck, M. & Hertzog, P. J. Characterization of the type I interferon locus and identification of novel genes. Genomics 84, 331\u2013345 (2004).","journal-title":"Genomics"},{"key":"6421_CR13","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1128\/IAI.00629-08","volume":"76","author":"UM Nagarajan","year":"2008","unstructured":"Nagarajan, U. M. et al. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect. Immun. 76, 4642\u20134648 (2008).","journal-title":"Infect. Immun."},{"key":"6421_CR14","doi-asserted-by":"publisher","first-page":"E10981","DOI":"10.1073\/pnas.1712514114","volume":"114","author":"ML Stone","year":"2017","unstructured":"Stone, M. L. et al. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. Proc. Natl Acad. Sci. USA 114, E10981\u2013E10990 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6421_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8, 1093 (2017).","journal-title":"Nat. Commun."},{"key":"6421_CR16","doi-asserted-by":"publisher","first-page":"43843","DOI":"10.18632\/oncotarget.5983","volume":"6","author":"TZ Tan","year":"2015","unstructured":"Tan, T. Z. et al. CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype. Oncotarget 6, 43843\u201343852 (2015).","journal-title":"Oncotarget"},{"key":"6421_CR17","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).","journal-title":"Nat. Commun."},{"key":"6421_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ygyno.2007.10.035","volume":"108","author":"J Greenaway","year":"2008","unstructured":"Greenaway, J., Moorehead, R., Shaw, P. & Petrik, J. Epithelial\u2013stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Gynecol. Oncol. 108, 385\u2013394 (2008).","journal-title":"Gynecol. Oncol."},{"key":"6421_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/path.4536","volume":"236","author":"HS Leong","year":"2015","unstructured":"Leong, H. S. et al. Efficient molecular subtype classification of high-grade serous ovarian cancer. J. Pathol. 236, 272\u2013277 (2015).","journal-title":"J. Pathol."},{"key":"6421_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/cancers10080242","volume":"10","author":"GM Rodriguez","year":"2018","unstructured":"Rodriguez, G. M., Galpin, K. J. C., McCloskey, C. W. & Vanderhyden, B. C. The tumor microenvironment of epithelial ovarian cancer and its influence on response to immunotherapy. Cancers 10, 242 (2018).","journal-title":"Cancers"},{"key":"6421_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/imt.11.20","volume":"3","author":"CC Preston","year":"2011","unstructured":"Preston, C. C., Goode, E. L., Hartmann, L. C., Kalli, K. R. & Knutson, K. L. Immunity and immune suppression in human ovarian cancer. Immunotherapy 3, 539\u2013556 (2011).","journal-title":"Immunotherapy"},{"key":"6421_CR22","doi-asserted-by":"publisher","first-page":"11284","DOI":"10.1073\/pnas.92.24.11284","volume":"92","author":"SY Hwang","year":"1995","unstructured":"Hwang, S. Y. et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons \u03b1 and \u03b2 and alters macrophage responses. Proc. Natl Acad. Sci. USA. 92, 11284\u201311288 (1995).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"6421_CR23","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1158\/0008-5472.CAN-21-0774","volume":"81","author":"K Nesic","year":"2021","unstructured":"Nesic, K. et al. Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high-grade serous ovarian carcinoma. Cancer Res. 81, 4709\u20134772 (2021).","journal-title":"Cancer Res."},{"key":"6421_CR24","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-21-4012","volume":"82","author":"G-Y Ho","year":"2022","unstructured":"Ho, G.-Y. et al. Epithelial-to-mesenchymal transition supports ovarian carcinosarcoma tumorigenesis and confers sensitivity to microtubule-targeting with eribulin. Cancer Res. 82, 4457\u20134473 (2022).","journal-title":"Cancer Res."},{"key":"6421_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","volume":"565","author":"JJ Ishizuka","year":"2019","unstructured":"Ishizuka, J. J. et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature 565, 43\u201348 (2019).","journal-title":"Nature"},{"key":"6421_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(02)00626-8","volume":"108","author":"P Salomoni","year":"2002","unstructured":"Salomoni, P. & Pandolfi, P. P. The role of PML in tumor suppression. Cell 108, 165\u2013170 (2002).","journal-title":"Cell"},{"key":"6421_CR27","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.1128\/JVI.00775-14","volume":"88","author":"J Hou","year":"2014","unstructured":"Hou, J. et al. Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection. J. Virol. 88, 12254\u201312264 (2014).","journal-title":"J. Virol."},{"key":"6421_CR28","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","volume":"76","author":"J Walton","year":"2016","unstructured":"Walton, J. et al. CRISPR\/Cas9-mediated Trp53and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma. Cancer Res. 76, 6118\u20136129 (2016).","journal-title":"Cancer Res."},{"key":"6421_CR29","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","volume":"128","author":"L Chen","year":"2005","unstructured":"Chen, L. et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128, 1437\u20131444 (2005).","journal-title":"Gastroenterology"},{"key":"6421_CR30","doi-asserted-by":"publisher","first-page":"e22200","DOI":"10.1371\/journal.pone.0022200","volume":"6","author":"V Fran\u00e7ois-Newton","year":"2011","unstructured":"Fran\u00e7ois-Newton, V. et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon \u03b1 response. PLoS ONE 6, e22200 (2011).","journal-title":"PLoS ONE"},{"key":"6421_CR31","doi-asserted-by":"crossref","unstructured":"Lheureux, S., Braunstein, M. & Oza, A. M. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J. Clin. 69, 280\u2013304 (2019).","DOI":"10.3322\/caac.21559"},{"key":"6421_CR32","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s43018-022-00443-5","volume":"3","author":"FM Barriga","year":"2022","unstructured":"Barriga, F. M. et al. MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis. Nat. Cancer 3, 1367\u20131385 (2022).","journal-title":"Nat. Cancer"},{"key":"6421_CR33","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224\u20131231 (2012).","journal-title":"Nat. Med."},{"key":"6421_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4942","volume":"243","author":"A Capobianco","year":"2017","unstructured":"Capobianco, A., Cottone, L., Monno, A., Manfredi, A. A. & Rovere-Querini, P. The peritoneum: healing, immunity, and diseases. J. Pathol. 243, 137\u2013147 (2017).","journal-title":"J. Pathol."},{"key":"6421_CR35","doi-asserted-by":"publisher","unstructured":"Mitra, A. K. in Tumor Metastasis (ed. Xu, K.) Ch. 3 https:\/\/doi.org\/10.5772\/64700 (IntechOpen, 2016).","DOI":"10.5772\/64700"},{"key":"6421_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","volume":"21","author":"KF Roby","year":"2000","unstructured":"Roby, K. F. et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21, 585\u2013591 (2000).","journal-title":"Carcinogenesis"},{"key":"6421_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pep.2013.10.019","volume":"94","author":"SA Stifter","year":"2014","unstructured":"Stifter, S. A. et al. Purification and biological characterization of soluble, recombinant mouse IFN\u03b2 expressed in insect cells. Protein Expr. Purif. 94, 7\u201314 (2014).","journal-title":"Protein Expr. Purif."},{"key":"6421_CR38","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & Van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."},{"key":"6421_CR39","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. https:\/\/www.r-project.org (R Foundation for Statistical Computing, 2019)."},{"key":"6421_CR40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"6421_CR41","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis, S. & Meltzer, P. S. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23, 1846\u20131847 (2007).","journal-title":"Bioinformatics"},{"key":"6421_CR42","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439\u20133440 (2005).","journal-title":"Bioinformatics"},{"key":"6421_CR43","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat. Protoc. 4, 1184\u20131191 (2009).","journal-title":"Nat. Protoc."},{"key":"6421_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1471-2105-7-261","volume":"7","author":"ME Ritchie","year":"2006","unstructured":"Ritchie, M. E. et al. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7, 261 (2006).","journal-title":"BMC Bioinformatics"},{"key":"6421_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bioinformatics\/btp053","volume":"25","author":"DJ McCarthy","year":"2009","unstructured":"McCarthy, D. J. & Smyth, G. K. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25, 765\u2013771 (2009).","journal-title":"Bioinformatics"},{"key":"6421_CR46","doi-asserted-by":"crossref","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","DOI":"10.1073\/pnas.0506580102"},{"key":"6421_CR47","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/bioinformatics\/btw623","volume":"33","author":"M Alhamdoosh","year":"2017","unstructured":"Alhamdoosh, M. et al. Combining multiple tools outperforms individual methods in gene set enrichment analyses. Bioinformatics 33, 414\u2013424 (2017).","journal-title":"Bioinformatics"},{"key":"6421_CR48","doi-asserted-by":"publisher","first-page":"e1006361","DOI":"10.1371\/journal.pcbi.1006361","volume":"14","author":"L Tian","year":"2018","unstructured":"Tian, L. et al. scPipe: a flexible R\/Bioconductor preprocessing pipeline for single-cell RNA-sequencing data. PLoS Comput. Biol. 14, e1006361 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"6421_CR49","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).","journal-title":"Nucleic Acids Res."},{"key":"6421_CR50","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"6421_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21105\/joss.00018","volume":"1","author":"MJ Wakefield","year":"2016","unstructured":"Wakefield, M. J. Xenomapper: mapping reads in a mixed species context. J. Open Source Softw. 1, 18 (2016).","journal-title":"J. Open Source Softw."},{"key":"6421_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"6421_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).","journal-title":"Genome Biol."},{"key":"6421_CR54","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1093\/nar\/gkv412","volume":"43","author":"R Liu","year":"2015","unstructured":"Liu, R. et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 43, e97\u2013e97 (2015).","journal-title":"Nucleic Acids Res."},{"key":"6421_CR55","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gks461","volume":"40","author":"D Wu","year":"2012","unstructured":"Wu, D. & Smyth, G. K. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 40, e133 (2012).","journal-title":"Nucleic Acids Res."},{"key":"6421_CR56","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1214\/16-AOAS920","volume":"10","author":"B Phipson","year":"2016","unstructured":"Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann. Appl. Stat. 10, 946\u2013963 (2016).","journal-title":"Ann. Appl. Stat."},{"key":"6421_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10 (2011).","journal-title":"EMBnet.journal"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06421-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06421-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06421-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T12:06:43Z","timestamp":1693397203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06421-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":57,"journal-issue":{"issue":"7976","published-print":{"date-parts":[[2023,8,31]]}},"alternative-id":["6421"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06421-w","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors P.J.H., Z.R.C.M., N.B., S.S.L., N.A.d.W., N.E.M. and A.Y.M. are listed as inventors on the patent PCT\/AU2018\/050054 regarding use of IFN\u03b5 as a method of treatment for cancer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}